Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Verastem Stock Is Rising Today


Shares of Verastem (NASDAQ: VSTM) -- a small-cap oncology-focused biotech -- were up by 10.9% as of 2:12 p.m. EDT on Monday. The company has not reported any news, though, so the reason behind that stock market rise is a bit of a mystery. However, that gain essentially recouped the stock's Friday decline.

Verastem's stock has been highly volatile all year, and not just because of the coronavirus-fueled market crash. On April 27, its shares plunged by more than 40% after data from a study failed to impress investors. Specifically, in a clinical trial investigating the efficacy of Verastem's combination of VS-6766 and Defactinib as a treatment for aggressive tumors, only one of the 10 patients treated experienced a tumor reduction.

Image Source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments